ABOS Acumen Pharmaceuticals, Inc.
$2.38▲ +5.31%
Healthcare
Other
After hours
$2.40▲ +0.84%
Oct 28, 5:55 PM ET
Volume 1.41M
Avg Volume (10D) 768.4K
Key Metrics & Fundamentals
Market Cap
$172.14M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.50 - 3.60
% vs 50 MA
-4.15%
% vs 200 MA
-5.04%
RSI-14
58.7
MACD Histogram
+0.0800
Beta (1Y vs SPY)
1.98
Free Cash Flow
-$26.65M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$24.97M
COGS
–
Operating Exp
$25.81M
Operating Income
-$25.81M
EBIT
-$25.81M
Pretax Income
-$25.37M
Net Income
-$25.37M
EPS (Diluted)
-0.35
Price & Volume History
Loading chart…
Recent News
Acumen Pharmaceuticals Inc (ABOS) (Q3 2026) Earnings Call Highlights: $79 Million Cash Runway ...
GuruFocus.com · Oct 26, 2026 7:01 PM ET
Acumen Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary
Moby · Oct 26, 2026 12:42 PM ET
Acumen Pharmaceuticals (ABOS) Q3 2026 Earnings Call Transcript
Motley Fool · Oct 26, 2026 12:12 PM ET
Acumen Pharmaceuticals Reports Smaller Q3 Loss, Shares Rise as Phase 2 Alzheimer’s Data Approach
InvestorsHub · Oct 26, 2026 10:09 AM ET
Acumen Pharmaceuticals Q3 Earnings Call Highlights
MarketBeat · Oct 26, 2026 10:02 AM ET
Acumen Pharmaceuticals beats Q3 estimates, shares jump 6%
Investing.com · Oct 26, 2026 8:07 AM ET
Acumen Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Highlights
GlobeNewswire · Oct 26, 2026 7:00 AM ET
Acumen Pharmaceuticals to Present Preliminary Baseline Characteristics and Data on Care Experiences and Participation in Phase 2 ALTITUDE-AD Trial at the 19th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference
GlobeNewswire · Oct 22, 2026 7:30 AM ET
Acumen Pharmaceuticals to Report Third Quarter Financial Results on October 26, 2026
GlobeNewswire · Oct 19, 2026 4:00 PM ET
4 Alzheimer's Drug Stocks to Watch on World Alzheimer's Day
Zacks · Sep 21, 2026 12:40 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See ABOS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.